Tandem Diabetes Care Announces Upcoming Conference Presentations

Tandem Diabetes Care Announces Upcoming Conference Presentations

February 08, 2024 | Last Trade: US$16.86 0.40 -2.32

SAN DIEGO / Feb 08, 2024 / Business Wire / Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will present a company update at the following investor conferences:

Citi’s 2024 Unplugged Medtech and Life Sciences Access Day on Thursday, February 29, 2024 at 1:00pm Eastern Time (10:00am Pacific Time),
TD Cowen 44^th Annual Health Care Conference on Monday, March 4, 2024 at 1:30pm Eastern Time (10:30am Pacific Time),
2024 Raymond James Institutional Investor Conference on Wednesday, March 6, 2024 at 11:00am Eastern Time (8:00am Pacific Time),
Oppenheimer 34^th Annual Healthcare MedTech & Services Conference on Tuesday, March 12, 2024 at 1:20pm Eastern Time (10:20am Pacific Time), and
Barclays Global Healthcare Conference on Wednesday, March 13, 2024 at 3:35pm Eastern Time (12:35pm Pacific Time).

The Company update presentations will be webcast live, and an archive recording will be available for 30 days. The link to the live webcast and archive will be accessible on Tandem Diabetes Care’s Investor Center website located at http://investor.tandemdiabetes.com in the “Events & Presentations” section.

About Tandem Diabetes Care, Inc.

Tandem Diabetes Care, Inc., a global insulin delivery and diabetes technology company based in San Diego, California, creates new possibilities for people living with diabetes, their loved ones, and healthcare providers through a positively different experience. The Company’s human-centered approach to design, development, and support delivers innovative products and services for people who use insulin. Tandem manufactures and sells the t:slim X2 insulin pump with Control-IQ technology. For more information, visit tandemdiabetes.com.

Tandem Diabetes Care, t:slim X2, and Control-IQ are either registered trademarks or trademarks of Tandem Diabetes Care, Inc. in the US and/or other countries.

Follow Tandem Diabetes Care on Twitter @tandemdiabetes; use #tslimX2 and #TandemDiabetes.
Follow Tandem Diabetes Care on Facebook at www.facebook.com/TandemDiabetes.
Follow Tandem Diabetes Care on LinkedIn at https://www.linkedin.com/company/tandemdiabetes.

Stock Quote

Last Trade:	US$16.86
Daily Change:	-0.40 -2.32
Daily Volume:	943,013
Market Cap:	US$1.110B

March 19, 2025 Tandem Diabetes Care Announces NEJM Publication of Positive Pivotal Study Outcomes with Control-IQ+ AID Technology in Type 2 Diabetes March 18, 2025 Tandem Diabetes Care Launches New Control-IQ+ Automated Insulin Delivery Technology in the United States February 26, 2025 Tandem Diabetes Care Announces Fourth Quarter and Full Year 2024 Financial Results and 2025 Financial Guidance February 25, 2025 Tandem Diabetes Care Announces FDA Clearance of Control-IQ+ Automated Insulin Delivery Technology for People with Type 2 Diabetes February 13, 2025 Tandem Diabetes Care Announces Upcoming Conference Presentations LOAD MORE NEWS

Featured Stock

Recursion Pharmaceuticals is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest....

CLICK TO LEARN MORE

Featured Stock

Cue Biopharma is developing the first-ever class of therapeutics for the treatment of cancer that mimic the natural signals, or “Cues”, of the immune system. This novel class of injectable biologics selectively engages and modulates tumor-specific T cells directly within the patient’s body to transform...

CLICK TO LEARN MORE